N - 3 fatty acids: Functional differences between food intake, oral supplementation and drug treatments

International Journal of Cardiology

Volumn 170, Issue 2 SUPPL.1, 2013, Pages

  Marangoni, Franca ^a   Poli, Andrea ^a  

^a Nutrition Foundation of Italy   (Italy)

Author keywords

Bioavailability; Food intake; n 3 PUFA; Supplementation

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; OMEGA 3 FATTY ACID;

ARTICLE; BIOCHEMICAL COMPOSITION; CARDIOVASCULAR RISK; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FOOD INTAKE; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; TREATMENT INDICATION;

BIOAVAILABILITY; FOOD INTAKE; N-3 PUFA; SUPPLEMENTATION;

ADMINISTRATION, ORAL; ANIMALS; CHEMISTRY, PHARMACEUTICAL; CORONARY DISEASE; DIETARY SUPPLEMENTS; EATING; FATTY ACIDS, OMEGA-3; FISHES; HUMANS;

EID: 84890244899     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.06.039     Document Type: Article

References (34)

1. J. Dyerberg, H.O. Bang, and N. Hjorne Fatty acid composition of the plasma lipids in Greenland Eskimos Am J Clin Nutr 28 1975 958 966
2. R.F. Gillum, M.E. Mussolino, and J.H. Madans The relationship between fish consumption and stroke incidence. The NHANES I Epidemiologic Follow-up Study (National Health and Nutrition Examination Survey) Arch Intern Med 156 1996 537 542 (Pubitemid 26077356)
3. M.L. Daviglus, J. Stamler, and A.J. Orencia Fish consumption and the 30-year risk of fatal myocardial infarction N Engl J Med 336 1997 1046 1053 (Pubitemid 27163856)
4. F.B. Hu, L. Bronner, and W.C. Willett Fish and omega-3 fatty acid intake and risk of coronary heart disease in women JAMA 287 2002 1815 1821 (Pubitemid 34303626)
5. C.M. Albert, H. Campos, and M.J. Stampfer Blood levels of long-chain n - 3 fatty acids and the risk of sudden death N Engl J Med 346 2002 1113 1118 (Pubitemid 34984601)
6. H.M. Karvonen, A. Aro, N.S. Tapola, I. Salminen, M.I. Uusitupa, and E.S. Sarkkinen Effect of α-linolenic acid-rich Camelina sativa oil on serum fatty acid composition and serum lipids in hypercholesterolemic subjects Metabolism 51 2002 1253 1260 (Pubitemid 35174145)
7. L.M. Arterburn, E.B. Hall, and H. Oken Distribution, interconversion, and dose response of n - 3 fatty acids in humans Am J Clin Nutr 83 6 Suppl. 2006 1467S 1476S (Pubitemid 44713087)
8. G.C. Burdge, and S.A. Wootton Conversion of α-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women Br J Nutr 88 2002 411 420 (Pubitemid 35251957)
9. G. Barcelo-Coblijn, E.J. Murphy, R. Othman, M.H. Moghadasian, T. Kashour, and J.K. Friel Flaxseed oil and fish-oil capsule consumption alters human red blood cell n - 3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n - 3 fatty acid Am J Clin Nutr 88 2008 801 809
10. A. Chisholm, J. Mann, and M. Skeaff A diet rich in walnuts favourably influences plasma fatty acid profile in moderately hyperlipidaemic subjects Eur J Clin Nutr 52 1998 12 16 (Pubitemid 28040760)
11. F. Marangoni, C. Colombo, A. Martiello, E. Negri, and C. Galli The fatty acid profiles in a drop of blood from a fingertip correlate with physiological, dietary and lifestyle parameters in volunteers Prostaglandins Leukot Essent Fatty Acids 76 2007 87 92 (Pubitemid 46217227)
12. G.C. Burdge, and P.C. Calder Dietary α-linolenic acid and health-related outcomes: a metabolic perspective Nutr Res Rev 19 2006 26 52 (Pubitemid 44174292)
13. K. He Fish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease - eat fish or take fish oil supplement? Prog Cardiovasc Dis 52 2009 95 114
14. D. Mozaffarian, and E.B. Rimm Fish intake, contaminants, and human health: evaluating the risks and the benefits JAMA 296 2006 1885 1899 (Pubitemid 44596197)
15. European Food Safety Authority Opinion of the Scientific Panel on contaminants in the food chain [CONTAM] related to the safety assessment of wild and farmed fish EFSA J 236 2005 1 118
16. B. Koletzko, I. Cetin, and J.T. Brenna Dietary fat intakes for pregnant and lactating women Br J Nutr 98 2007 873 877 (Pubitemid 47543443)
17. D. Mozaffarian, R.N. Lemaitre, and L.H. Kuller Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study Circulation 107 2003 1372 1377 (Pubitemid 36350734)
18. R.A. Racine, and R.J. Deckelbaum Sources of the very-long-chain unsaturated omega-3 fatty acids: eicosapentaenoic acid and docosahexaenoic acid Curr Opin Clin Nutr Metab Care 10 2007 123 128 (Pubitemid 46220302)
19. K.M. Chee, J.X. Gong, and D.M. Rees Fatty acid content of marine oil capsules Lipids 25 1990 523 528 (Pubitemid 20327612)
20. H.E. Bays Safety considerations with omega-3 fatty acid therapy Am J Cardiol 99 2007 35C 43C
21. T.A. Mori, and R.J. Woodman The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans Curr Opin Clin Nutr Metab Care 9 2006 95 104 (Pubitemid 44090031)
22. F. Visioli, P. Risé, M.C. Barassi, F. Marangoni, and C. Galli Dietary intake of fish vs. formulations leads to higher plasma concentrations of n - 3 fatty acids Lipids 38 2003 415 418 (Pubitemid 36724299)
23. F. Marangoni, C. Colombo, A. Martiello, A. Poli, R. Paoletti, and C. Galli Levels of the n - 3 fatty acid eicosapentaenoic acid in addition to those of alpha linolenic acid are significantly raised in blood lipids by the intake of four walnuts a day in humans Nutr Metab Cardiovasc Dis 17 2007 457 461 (Pubitemid 47069911)
24. W.S. Harris, J.V. Pottala, S.A. Sands, and P.G. Jones Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids Am J Clin Nutr 86 2007 1621 1625 (Pubitemid 350232175)
25. J.P. Schuchardt, I. Schneider, H. Meyer, J. Neubronner, C. von Schacky, and A. Hahn Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations - a comparative bioavailability study of fish oil vs. krill oil Lipids Health Dis 10 2011 145
26. J. Dyerberg, P. Madsen, J.M. Møller, I. Aardestrup, and E.B. Schmidt Bioavailability of marine n - 3 fatty acid formulations Prostaglandins Leukot Essent Fatty Acids 83 2010 137 141
27. J. Neubronner, J.P. Schuchardt, G. Kressel, M. Merkel, C. von Schacky, and A. Hahn Enhanced increase of omega-3 index in response to long-term n - 3 fatty acid supplementation from triacylglycerides versus ethyl esters Eur J Clin Nutr 65 2011 247 254
28. F. Marangoni, M.T. Angeli, and S. Colli Changes of n - 3 and n - 6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout Biochim Biophys Acta 1210 1993 55 62
29. R. Marchioli, F. Barzi, and E. Bomba Early protection against sudden death by n - 3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione Circulation 105 2002 1897 1903 (Pubitemid 34437615)
30. L.G. Gao, J. Cao, Q.X. Mao, X.C. Lu, X.L. Zhou, and L. Fan Influence of omega-3 polyunsaturated fatty acid-supplementation on platelet aggregation in humans: a meta-analysis of randomized controlled trials Atherosclerosis 226 2013 328 334
31. J.J. Andreasen, and E.B. Schmidt Therapeutic potential of marine n - 3 fatty acids in CABG patients Curr Opin Pharmacol 12 2012 142 146
32. S.R. Eussen, J.M. Geleijnse, E.J. Giltay, C.J. Rompelberg, O.H. Klungel, and D. Kromhout Effects of n - 3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction Eur Heart J 33 2012 1582 1588
33. C. Galli, F.M. Maggi, P. Risé, and C.R. Sirtori Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements Br J Clin Pharmacol 74 2012 60 65
34. European Food Safety Authority Scientific opinion on the tolerable upper intake level of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) EFSA J 10 2012 2815 2863